Leading Irish shares add €1.25bn in value with Moderna vaccine boost                

AIB, Bank of Ireland and Ryanair all boosted by vaccine news

The Moderna vaccine has an additional advantage in that it can be stored near fridge temperatures and without the Arctic-low temperature required by the Pfizer-BioNTech shot.

Leading Irish stock market firms for a second successive Monday added a cumulative €1.25bn after Moderna became the latest pharma firm to publish outstanding results of an advanced trial for a Covid-19 vaccine, promising to lift the siege on economies around the world.  

The second buying spree in a week came after Moderna of the US said its vaccine trial of 30,000 people showed a success rate of 94.5%, bettering even the outstanding performance of Pfizer and Germany’s BioNTech in its trial.